Skip to main content
. 2024 Sep 27;31(10):5821–5831. doi: 10.3390/curroncol31100432

Figure 4.

Figure 4

Overall survival time in patients with HCC treated with Atez/Bev. (A) Kaplan–Meier curves for overall survival in the Atez/Bev-TACE sequential therapy group and the Atez/Bev monotherapy group. (B) Kaplan–Meier curves for overall survival in the Atez/Bev-TACE sequential therapy group and the Atez/Bev monotherapy group in patients with intermediate-stage HCC.